Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Real-Time Price · USD
37.84
+0.18 (0.48%)
Apr 1, 2026, 3:33 PM EDT - Market open

GRDN Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,4491,2281,046908.91792.07
Revenue Growth (YoY)
17.93%17.42%15.10%14.75%7.63%
Cost of Revenue
1,156984.04837.88723.04630.81
Gross Profit
292.72244.37208.31185.87161.27
Selling, General & Admin
220.02307.29167.36133.88118.09
Other Operating Expenses
----13.03
Total Operating Expenses
220.02307.29167.36133.88131.12
Operating Income
72.7-62.9240.9551.9930.15
Interest Expense
-0.67-3.28-2.86-1.93-1.64
Other Non-Operating Income (Expense)
1.39-0.28-0.37-0.4-0.19
Total Non-Operating Income (Expense)
0.72-3.56-3.23-2.33-1.82
Pretax Income
73.42-66.4837.7249.6628.33
Provision for Income Taxes
24.474.56---
Net Income
49.22-110.05035.4216.31
Minority Interest in Earnings
-0.2639.0137.72-14.24-12.01
Net Income to Common
49.22-110.05035.4216.31
Net Income Growth
---117.12%-18.20%
Shares Outstanding (Basic)
6262000
Shares Outstanding (Diluted)
6362000
Shares Change (YoY)
2.08%62005711.00%---
EPS (Basic)
0.79-1.77-354210.00163140.00
EPS (Diluted)
0.78-1.77-354210.00163140.00
EPS Growth
---117.12%-
Shares Outstanding
63.3263.29000
Free Cash Flow
80.7141.5956.2631.7549.22
Free Cash Flow Growth
94.05%-26.08%77.20%-35.48%11.17%
Free Cash Flow Per Share
1.280.67---
Gross Margin
20.21%19.89%19.91%20.45%20.36%
Operating Margin
5.02%-5.12%3.91%5.72%3.81%
Profit Margin
3.38%-5.78%3.61%5.46%3.58%
FCF Margin
5.57%3.39%5.38%3.49%6.21%
EBITDA
95.04-43.1559.1868.5546.68
EBITDA Margin
6.56%-3.51%5.66%7.54%5.89%
EBIT
72.7-62.9240.9551.9930.15
EBIT Margin
5.02%-5.12%3.91%5.72%3.81%
Effective Tax Rate
33.32%-6.85%0.00%0.00%0.00%
Updated Mar 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q